157 related articles for article (PubMed ID: 21314901)
1. Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves.
Vitour D; Guillotin J; Sailleau C; Viarouge C; Desprat A; Wolff F; Belbis G; Durand B; Bakkali-Kassimi L; Breard E; Zientara S; Zanella G
Vet Res; 2011 Feb; 42(1):18. PubMed ID: 21314901
[TBL] [Abstract][Full Text] [Related]
2. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
[TBL] [Abstract][Full Text] [Related]
3. Colostral transmission of BTV-8 antibodies from dairy cows six years after vaccination.
Ayrle H; Mevissen M; Kaske M; Vögtlin A; Fricker R; Hoffmann B; Büttner M; Marinovic Z; Walkenhorst M
Vaccine; 2018 Sep; 36(39):5807-5810. PubMed ID: 30100070
[TBL] [Abstract][Full Text] [Related]
4. Interference of colostral antibodies with response to a Bluetongue serotype 8 inactivated vaccine in lambs born from hyperimmune ewes.
Leemans J; Hamers C; Chery R; Bibard A; Besancon L; Duboeuf M; Hudelet P; Goutebroze S; Kirschvink N
Vaccine; 2013 Apr; 31(15):1975-80. PubMed ID: 23422141
[TBL] [Abstract][Full Text] [Related]
5. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine.
Oura CA; Wood JL; Floyd T; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Simmons H; Batten CA
Vaccine; 2010 Mar; 28(15):2749-53. PubMed ID: 20123052
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting Seroconversion Rates in Cattle Vaccinated with Two Commercial Inactivated BTV-8 Vaccines Under Field Conditions.
Vitale N; Radaelli MC; Chiavacci L; Paoletti M; Teodori L; Savini G
Transbound Emerg Dis; 2016 Apr; 63(2):175-83. PubMed ID: 24903759
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Comtet L; Lövgren Bengtsson K; Pringle J; Zientara S; Valarcher JF
Clin Vaccine Immunol; 2013 Aug; 20(8):1115-22. PubMed ID: 23720365
[TBL] [Abstract][Full Text] [Related]
8. IgE responses to bluetongue virus (BTV) serotype 11 after immunization with inactivated BTV and challenge infection.
Odeón AC; Gershwin LJ; Osburn BI
Comp Immunol Microbiol Infect Dis; 1999 Apr; 22(2):145-62. PubMed ID: 10051184
[TBL] [Abstract][Full Text] [Related]
9. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
10. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
[TBL] [Abstract][Full Text] [Related]
11. BTV antibody longevity in cattle five to eight years post BTV-8 vaccination.
Ries C; Beer M; Hoffmann B
Vaccine; 2019 May; 37(20):2656-2660. PubMed ID: 30979569
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.
Martinelle L; Dal Pozzo F; Thys C; De Leeuw I; Van Campe W; De Clercq K; Thiry E; Saegerman C
Vet Res; 2018 Jul; 49(1):63. PubMed ID: 30012223
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
[TBL] [Abstract][Full Text] [Related]
15. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine.
Oura CA; Edwards L; Batten CA
Vaccine; 2012 Jan; 30(2):112-5. PubMed ID: 22067262
[TBL] [Abstract][Full Text] [Related]
17. Experimental bluetongue virus superinfection in calves previously immunized with bluetongue virus serotype 8.
Martinelle L; Dal Pozzo F; Sarradin P; Van Campe W; De Leeuw I; De Clercq K; Thys C; Thiry E; Saegerman C
Vet Res; 2016 Jul; 47(1):73. PubMed ID: 27465686
[TBL] [Abstract][Full Text] [Related]
18. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence after vaccination of cattle and sheep against Bluetongue Virus (BTV) serotype 8 in Sweden.
Hultén C; Frössling J; Chenais E; Sternberg Lewerin S
Transbound Emerg Dis; 2013 Oct; 60(5):438-47. PubMed ID: 22889362
[TBL] [Abstract][Full Text] [Related]
20. [Vaccination against bluetongue serotype 8 in the Netherlands].
Kuijk H; Jansen M; Moulin V; Makoschey B
Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
